Alcentra Capital Corp. (NASDAQ:ABDC) shares reached a new 52-week low on Wednesday . The stock traded as low as $10.19 and last traded at $10.23, with a volume of 46,247 shares. The stock had previously closed at $10.39.

Several research analysts have commented on ABDC shares. Raymond James Financial, Inc. downgraded Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and dropped their price target for the company from $16.00 to $14.00 in a research report on Monday, July 17th. DA Davidson assumed coverage on Alcentra Capital Corp. in a research report on Wednesday, July 5th. They set a “buy” rating and a $15.00 price target for the company. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $14.00 price target on shares of Alcentra Capital Corp. in a research report on Tuesday, July 25th. TheStreet downgraded Alcentra Capital Corp. from a “b” rating to a “c+” rating in a research report on Monday, July 24th. Finally, ValuEngine downgraded Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $13.50.

The firm’s 50 day moving average is $10.74 and its 200-day moving average is $12.47.

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 5th. Investors of record on Saturday, September 30th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $1.36 annualized dividend and a dividend yield of 13.35%. Alcentra Capital Corp.’s payout ratio is -1,700.00%.

In other news, Director Steven H. Reiff purchased 11,668 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The shares were purchased at an average price of $10.72 per share, with a total value of $125,080.96. Following the purchase, the director now directly owns 7,000 shares of the company’s stock, valued at approximately $75,040. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 4.96% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Muzinich & Co. Inc. increased its position in shares of Alcentra Capital Corp. by 34.7% in the 2nd quarter. Muzinich & Co. Inc. now owns 610,164 shares of the asset manager’s stock worth $8,292,000 after purchasing an additional 157,251 shares during the last quarter. UBS Group AG increased its position in shares of Alcentra Capital Corp. by 20.7% in the 1st quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock worth $3,558,000 after purchasing an additional 44,387 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its position in shares of Alcentra Capital Corp. by 45.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 242,865 shares of the asset manager’s stock worth $3,300,000 after purchasing an additional 76,115 shares during the last quarter. Confluence Investment Management LLC increased its position in shares of Alcentra Capital Corp. by 2.7% in the 2nd quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock worth $2,847,000 after purchasing an additional 5,566 shares during the last quarter. Finally, Salem Investment Counselors Inc. bought a new stake in shares of Alcentra Capital Corp. in the 2nd quarter worth about $646,000. 31.49% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Alcentra Capital Corp. (ABDC) Hits New 12-Month Low at $10.19” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/18/alcentra-capital-corp-abdc-hits-new-12-month-low-at-10-19.html.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Receive News & Stock Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related stocks with our FREE daily email newsletter.